No annual revenue total was found in HEARTBEAM, INC.'s SEC filings.
Heartbeam, Inc. (BEATW) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$14.6 million.
Revenue
—
Net income (TTM)
$-20.30M
+0.2% vs year-ago TTM
Operating cash flow (TTM)
$-13.02M
+15.4% vs year-ago TTM
Free cash flow (TTM)
$-14.01M
+10.1% vs year-ago TTM
EPS (TTM)
$-0.50
+28.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
41.09M
+21.8% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BEATW (Nasdaq), BEAT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Santa Clara, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1779372
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$21.1M | -$19.9M | -$15.3M | -$13.0M | -$2.3M |
| Net income | -$21.0M | -$19.4M | -$14.6M | -$13.0M | -$4.4M |
| Diluted EPS | -$0.62 | -$0.73 | -$0.72 | -$1.59 | -$1.03 |
| Operating cash flow | -$14.0M | -$14.5M | -$12.1M | -$9.9M | -$3.2M |
| Free cash flow | -$14.6M | -$14.7M | -$12.3M | — | — |
| Total assets | $5.8M | $3.3M | $17.1M | $4.0M | $14.0M |
| Total liabilities | $3.2M | $1.6M | $1.2M | $1.7M | $588,000 |
| Stockholders' equity | $2.6M | $1.7M | $15.9M | $2.4M | $13.4M |
| Cash and investments | $4.4M | $2.4M | $16.2M | $3.6M | $13.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 6, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 24, 2026 | Jun 18, 2026 |
All 271 Heartbeam, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.